Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Atropine

Atropine

51-55-8

DISCOVER
Amobarbital - * psy CRS, 500mg

Amobarbital - * psy CRS, 500mg

57-43-2

DISCOVER
Agmatine sulfate

Agmatine sulfate

2482-00-0

DISCOVER
Amobarbital sodium - * psy CRS, 500mg

Amobarbital sodium - * psy CRS, 500mg

64-43-7

DISCOVER
AMOXICILLIN TRIHYDRATE  CRS (200 MG)

AMOXICILLIN TRIHYDRATE CRS (200 MG)

61336-70-7

DISCOVER
Amoxicillin 3H2O

Amoxicillin 3H2O

61336-70-7

DISCOVER
Ampicillin 3H2O

Ampicillin 3H2O

7177-48-2

DISCOVER
Acebutolol HCl

Acebutolol HCl

34381-68-5

DISCOVER
Altrenogest

Altrenogest

850-52-2

DISCOVER
Amfetamine sulfate - reference spectrum

Amfetamine sulfate - reference spectrum

NA

DISCOVER
Acetamidophenol-4

Acetamidophenol-4

103-90-2

DISCOVER
Acetylsalicylic acid

Acetylsalicylic acid

50-78-2

DISCOVER